Haibo Wu

829 total citations
17 papers, 714 citations indexed

About

Haibo Wu is a scholar working on Molecular Biology, Cell Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Haibo Wu has authored 17 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cell Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Haibo Wu's work include Cellular transport and secretion (6 papers), Biotin and Related Studies (3 papers) and Biochemical and Structural Characterization (3 papers). Haibo Wu is often cited by papers focused on Cellular transport and secretion (6 papers), Biotin and Related Studies (3 papers) and Biochemical and Structural Characterization (3 papers). Haibo Wu collaborates with scholars based in United States, China and India. Haibo Wu's co-authors include Daniel T. O’Connor, Robert J. Parmer, Sushil K. Mahata, Andrew Horvai, Christopher K. Glass, Karen S. Moulton, Huishan Wang, Laurent Taupenot, Jian Zhang and Yang Yang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Molecular and Cellular Biology.

In The Last Decade

Haibo Wu

16 papers receiving 702 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Haibo Wu 439 163 152 78 72 17 714
Li Zhong 520 1.2× 175 1.1× 72 0.5× 43 0.6× 70 1.0× 23 864
P.G. Suh 495 1.1× 151 0.9× 65 0.4× 49 0.6× 76 1.1× 28 732
Dan Lazar 783 1.8× 169 1.0× 149 1.0× 193 2.5× 61 0.8× 26 1.1k
Reid A. Phelps 696 1.6× 106 0.7× 104 0.7× 67 0.9× 43 0.6× 8 965
Morag Shaw 586 1.3× 107 0.7× 55 0.4× 66 0.8× 47 0.7× 7 763
P B Wilson 604 1.4× 123 0.8× 68 0.4× 102 1.3× 33 0.5× 8 839
Birger Herzog 924 2.1× 104 0.6× 288 1.9× 102 1.3× 81 1.1× 17 1.2k
Maya Mamarbachi 436 1.0× 206 1.3× 68 0.4× 125 1.6× 56 0.8× 16 914
Kin M. Choi 645 1.5× 61 0.4× 125 0.8× 58 0.7× 46 0.6× 5 846
W K Pollock 501 1.1× 76 0.5× 105 0.7× 79 1.0× 25 0.3× 11 977

Countries citing papers authored by Haibo Wu

Since Specialization
Citations

This map shows the geographic impact of Haibo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Wu more than expected).

Fields of papers citing papers by Haibo Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Wu. The network helps show where Haibo Wu may publish in the future.

Co-authorship network of co-authors of Haibo Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Haibo Wu. A scholar is included among the top collaborators of Haibo Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibo Wu. Haibo Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tong, Wenxue, Bin Shen, Yaohua Hu, et al.. (2025). Transcription Factor FOSL1 Promotes Cisplatin Resistance in Non-Small Cell Lung Cancer Cells by Modulating the Wnt3a/β-Catenin Signaling through Upregulation of PLIN3 Expression. Frontiers in Bioscience-Landmark. 30(3). 26898–26898. 1 indexed citations
3.
Sun, Weihua, Bingbing Wu, Bin Yang, et al.. (2020). [Genetic analysis and treatment for an infant with cerebral creatine deficiency syndrome type 2].. PubMed. 37(9). 1001–1004. 1 indexed citations
4.
Yu, Liming, Xue Dong, Xiaodong Xue, et al.. (2019). Protection of the myocardium against ischemia/reperfusion injury by punicalagin through an SIRT1-NRF-2-HO-1-dependent mechanism. Chemico-Biological Interactions. 306. 152–162. 47 indexed citations
5.
Yu, Liming, Xue Dong, Xiaodong Xue, et al.. (2019). Naringenin improves mitochondrial function and reduces cardiac damage following ischemia-reperfusion injury: the role of the AMPK-SIRT3 signaling pathway. Food & Function. 10(5). 2752–2765. 95 indexed citations
6.
Yu, Liming, Xue Dong, Jian Zhang, et al.. (2019). Naringenin Attenuates Myocardial Ischemia-Reperfusion Injury via cGMP-PKGIα Signaling and In Vivo and In Vitro Studies. Oxidative Medicine and Cellular Longevity. 2019. 1–15. 49 indexed citations
8.
Wang, Shijun, et al.. (2013). Impact of baseline prehypertension on cardiovascular events and all-cause mortality in the general population: A meta-analysis of prospective cohort studies. International Journal of Cardiology. 168(5). 4857–4860. 27 indexed citations
9.
Taylor, Carolyn V., Laurent Taupenot, Sushil K. Mahata, et al.. (2000). Formation of the Catecholamine Release-inhibitory Peptide Catestatin from Chromogranin A. Journal of Biological Chemistry. 275(30). 22905–22915. 69 indexed citations
10.
Mahata, Sushil K., Manjula Mahata, Haibo Wu, Robert J. Parmer, & Daniel T. O’Connor. (1999). Neurotrophin activation of catecholamine storage vesicle protein gene expression: signaling to chromogranin A biosynthesis. Neuroscience. 88(2). 405–424. 24 indexed citations
11.
Taupenot, Laurent, Sushil K. Mahata, Haibo Wu, & Daniel T. O’Connor. (1998). Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).. Journal of Clinical Investigation. 101(4). 863–876. 64 indexed citations
12.
Mahata, Sushil K., Manjula Mahata, Seung Hyun Yoo, et al.. (1997). A Novel, Catecholamine Release-Inhibitory Peptide from Chromogranin A: Autocrine Control of Nicotinic Cholinergic-Stimulated Exocytosis. Advances in pharmacology. 42. 260–264. 17 indexed citations
13.
Zhou, An, Thai Dinh, Haibo Wu, et al.. (1996). Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway.. Journal of Clinical Investigation. 98(1). 148–156. 103 indexed citations
14.
Wu, Haibo, Sushil K. Mahata, Manjula Mahata, et al.. (1995). A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A.. Journal of Clinical Investigation. 96(1). 568–578. 40 indexed citations
15.
Wu, Haibo, David J. Rozansky, Nicholas J. G. Webster, & Daniel T. O’Connor. (1994). Cell type-specific gene expression in the neuroendocrine system. A neuroendocrine-specific regulatory element in the promoter of chromogranin A, a ubiquitous secretory granule core protein.. Journal of Clinical Investigation. 94(1). 118–129. 29 indexed citations
16.
Wu, Haibo, et al.. (1994). Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene.. Molecular and Cellular Biology. 14(3). 2129–2139. 123 indexed citations
17.
Parmer, Robert J., et al.. (1993). Processing of chromaffin granule proteins: A profusion of proteases?. Neurochemistry International. 22(4). 361–367. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026